Title: From the Cover: Harmane-Induced Selective Dopaminergic Neurotoxicity in Caenorhabditis elegans.

Authors: Sammi, Shreesh Raj; Agim, Zeynep Sena; Cannon, Jason R

Published In Toxicol Sci, (2018 Feb 01)

Abstract: Parkinson's disease (PD) is a debilitating neurodegenerative disease. Although numerous exposures have been linked to PD etiology, causative factors for most cases remain largely unknown. Emerging data on the neurotoxicity of heterocyclic amines suggest that this class of compounds should be examined for relevance to PD. Here, using Caenorhabditis elegans as a model system, we tested whether harmane exposure produced selective toxicity to dopamine neurons that is potentially relevant to PD. Harmane is a known tremorigenic β-carboline (a type of heterocyclic amine) found in cooked meat, roasted coffee beans, and tobacco. Thus, this compound represents a potentially important exposure. In the nematode model, we observed dopaminergic neurons to be selectively vulnerable, showing significant loss in terms of structure and function at lower doses than other neuronal populations. In examining mechanisms of toxicity, we observed significant harmane-induced decreases in mitochondrial viability and increased reactive oxygen species levels. Blocking transport through the dopamine transporter (DAT) was not neuroprotective, suggesting that harmane is unlikely to enter the cell through DAT. However, a mitochondrial complex I activator did partially ameliorate neurodegeneration. Further, mitochondrial complex I activator treatment reduced harmane-induced dopamine depletion, measured by the 1-nonanol assay. In summary, we have shown that harmane exposure in C. elegans produces selective dopaminergic neurotoxicity that may bear relevance to PD, and that neurotoxicity may be mediated through mitochondrial mechanisms.

PubMed ID: 29069497

MeSH Terms: Animals; Caenorhabditis elegans/drug effects*; Dietary Exposure/adverse effects; Disease Models, Animal; Dopaminergic Neurons/drug effects*; Dopaminergic Neurons/metabolism; Dopaminergic Neurons/pathology; Harmine/analogs & derivatives*; Harmine/toxicity; Mitochondria/drug effects; Mitochondria/metabolism; Parkinson Disease, Secondary/chemically induced*; Parkinson Disease, Secondary/metabolism; Parkinson Disease, Secondary/pathology; Reactive Oxygen Species/metabolism